Mobivity (MFON) 10-Q 12 Aug 21 2021 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2021	Aug. 12, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2021
Document Transition Report	false
Entity File Number	000-53851
Entity Registrant Name	Mobivity Holdings Corp.
Entity Incorporation, State Country Code	NV
Tax Identification Number (TIN)	26-3439095
Entity Address, Address Line One	3133 West Frye Road
Entity Address, Address Line Two	# 215
Entity Address, City or Town	Chandler
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85226
City Area Code	877
Local Phone Number	282-7660
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		55,410,695
Current Fiscal Year End Date	--12-31
Entity Central Index Key	0001447380
Amendment Flag	false
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2021

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Current assets
Cash	$ 1,874,294	$ 3,282,820
Accounts receivable, net of allowance for doubtful accounts of $29,986 and $33,848, respectively	1,552,478	305,693
Contracts receivable, current	943,904	943,904
Other current assets	307,451	272,736
Total current assets	4,678,127	4,805,153
Goodwill	496,352	496,352
Right to use lease assets	1,296,574	57,482
Intangible assets, net	1,274,255	1,368,329
Contracts receivable, long term	943,904	1,415,856
Other assets	194,012	25,230
TOTAL ASSETS	8,883,224	8,168,402
Current liabilities
Accounts payable	3,296,698	1,935,411
Accrued interest	2,324	47,316
Accrued and deferred personnel compensation	427,220	224,881
Deferred revenue and customer deposits	508,736	606,597
Related party notes payable		80,000
Notes payable, net - current maturities	149,634	561,676
Operating lease liability	161,867	58,173
Other current liabilities	567,715	566,303
Total current liabilities	5,114,194	4,080,357
Non-current liabilities
Related party notes payable, net - long term	1,704,647
Notes payable, net - long term	982,654	1,499,001
Operating lease liability	1,305,219	13,296
Other long term liabilities	554,356	831,535
Total non-current liabilities	4,546,876	2,343,832
Total liabilities	9,661,070	6,424,189
Stockholders' equity (deficit)
Common stock, $0.001 par value; 100,000,000 shares authorized; 55,410,695 and 55,410,695, shares issued and outstanding	55,411	55,411
Equity payable	100,862	100,862
Additional paid-in capital	101,810,068	101,186,889
Accumulated other comprehensive income (loss)	(42,365)	(23,446)
Accumulated deficit	(102,701,822)	(99,575,503)
Total stockholders' equity (deficit)	(777,846)	1,744,213
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 8,883,224	$ 8,168,402

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Condensed Consolidated Balance Sheets [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 29,986	$ 33,848
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	55,410,695	55,410,695
Common stock, shares outstanding	55,410,695	55,410,695

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Revenues
Revenues	$ 2,792,828	$ 2,766,662	$ 5,250,418	$ 7,316,656
Cost of revenues	1,272,141	1,214,915	2,313,936	2,799,328
Gross profit	1,520,687	1,551,747	2,936,482	4,517,328
Operating expenses
General and administrative	957,400	1,003,146	2,246,770	2,249,922
Sales and marketing	1,111,693	495,616	2,008,443	1,303,623
Engineering, research, and development	674,035	521,597	1,397,985	2,199,127
Impairment of intangible assets			8,286
Depreciation and amortization	183,584	184,918	341,811	358,845
Total operating expenses	2,926,712	2,205,277	6,003,295	6,111,517
Loss from operations	(1,406,025)	(653,530)	(3,066,813)	(1,594,189)
Other income/(expense)
Interest income		76	5	913
Interest expense	(23,867)	(68,088)	(56,383)	(145,277)
Loss on disposal of fixed assets	(880)	(3,935)	(880)	(3,935)
Foreign currency gain (loss)	(1,774)	(52)	(2,248)	1,100
Total other income/(expense)	(26,521)	(71,999)	(59,506)	(147,199)
Loss before income taxes	(1,432,546)	(725,529)	(3,126,319)	(1,741,388)
Income tax expense
Net loss per share:	(1,432,546)	(725,529)	(3,126,319)	(1,741,388)
Other comprehensive loss, net of income tax
Foreign currency translation adjustments	(9,241)	(26,136)	(18,919)	(39,217)
Comprehensive loss	$ (1,441,787)	$ (751,665)	$ (3,145,238)	$ (1,780,605)
Net loss per share:
Basic and Diluted	$ (0.03)	$ (0.01)	$ (0.06)	$ (0.03)
Weighted average number of shares:
Basic and Diluted	55,410,695	51,615,469	55,410,695	51,524,778

Condensed Consolidated Statem_2

Condensed Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)	Common Stock [Member]	Equity Payable [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]	Total
Beginning balance, value at Dec. 31, 2019	$ 51,381	$ 100,862	$ 94,781,738	$ 8,780	$ (96,657,106)	$ (1,714,345)
Beginning balance, shares at Dec. 31, 2019	51,380,969
Issuance of common stock for options exercised	$ 1,556		1,932,411			$ 1,933,967
Issuance of common stock for options exercised, Shares	1,556,459					15,000
Issuance of common stock for warrants conversion	$ 1,360		1,639,448			$ 1,640,808
Issuance of common stock for warrants conversion, Shares	1,359,500
Issuance of common stock for debt settlement	$ 1,114		2,059,354			2,060,468
Issuance of common stock for debt settlement, Shares	1,113,767
Stock based compensation			773,938			773,938
Foreign currency translation adjustment				(32,226)		(32,226)
Net loss					(2,918,397)	(2,918,397)
Ending balance, value at Dec. 31, 2020	$ 55,411	100,862	101,186,889	(23,446)	(99,575,503)	1,744,213
Ending balance, shares at Dec. 31, 2020	55,410,695
Fair value of options issued with related party debt			119,103			119,103
Stock based compensation			504,076			504,076
Foreign currency translation adjustment				(18,919)		(18,919)
Net loss					(3,126,319)	(3,126,319)
Ending balance, value at Jun. 30, 2021	$ 55,411	$ 100,862	$ 101,810,068	$ (42,365)	$ (102,701,822)	$ (777,846)
Ending balance, shares at Jun. 30, 2021	55,410,695

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
OPERATING ACTIVITIES
Net loss	$ (1,432,546)	$ (725,529)	$ (3,126,319)	$ (1,741,388)	$ (2,918,397)
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debt expense			61,834	118,123
Adjustments due to ASC 606				(423,330)
Stock-based compensation			504,076	322,757
Loss on disposal of fixed assets	880	3,935	880	3,935
Intangible asset impairment			8,286
Depreciation and amortization expense			295,287	358,844
Increase (decrease) in cash resulting from changes in:
Accounts receivable			(1,308,619)	112,549
Other current assets			(38,087)	225,192
Operating lease assets/liabilities			46,525
Contracts receivable, long-term			471,952
Other assets			3,556	594
Accounts payable			1,361,286	497,070
Accrued interest			(1,242)	98,705
Accrued and deferred personnel compensation			201,819	(56,065)
Right to use leases			(277,178)	(11,627)
Other liabilities - current			1,411	(14,020)
Deferred revenue and customer deposits			(97,861)	341,194
Net cash used in operating activities			(1,892,394)	(167,467)
INVESTING ACTIVITIES
Purchases of equipment			(78,458)	(4,907)
Cash paid for patent activities				(8,755)
Capitalized software development costs			(190,699)	(112,681)
Net cash used in investing activities			(269,157)	(126,343)
FINANCING ACTIVITIES
Payments on notes payable			(436,426)	(222,430)
Payments on related party notes payable			(80,000)
Proceeds from notes payable				920,519
Proceeds from related party notes payable			1,280,000	139,300
Proceeds from conversion of common stock warrants				234,500
Net cash provided by (used in) financing activities			763,574	1,071,889
Effect of foreign currency translation on cash flow			(10,549)	(54,968)
Net change in cash			(1,408,526)	723,111
Cash at beginning of period			3,282,820	273,599	273,599
Cash at end of period	$ 1,874,294	$ 996,710	1,874,294	996,710	$ 3,282,820
Cash paid during period for:
Interest			101,375	$ 46,572
Fixed assets contributed by lessor			110,000
Initial non asset and lease liability			1,458,527
Refinancing of debt - related party			543,750
Debt discount on related party debt			$ 119,103

Nature of Operations and Basis

Nature of Operations and Basis of Presentation	6 Months Ended
	Jun. 30, 2021
Nature of Operations and Basis of Presentation [Abstract]
Nature of Operations and Basis of Presentation	1. Nature of Operations and Basis of Presentation Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized, data-driven mobile marketing campaigns. Our proprietary platforms, consisting of software available to phones, tablets, PCs, and Point of Sale (“POS”) systems, allow resellers, brands and enterprises to market their products and services to consumers through text messages sent directly to consumers via mobile phones, mobile smartphone applications, and dynamically printed receipt content. On November 14, 2018, we completed the acquisition of certain operating assets relating to Belly, Inc.’s proprietary digital customer loyalty platform, including client contracts, accounts receivable and intellectual property. We generate revenue by charging the resellers, brands and enterprises a per-message transactional fee, through fixed or variable software licensing fees, or via advertising fees. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X promulgated by the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and disclosures required by GAAP for annual financial statements. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on March 30, 2021. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of our condensed consolidated financial statements as of June 30, 2021, and for the three and six months ended June 30, 2021 and 2020. The results of operations for the three and six months ended June 30, 2021 are not necessarily indicative of the operating results for the full year ending December 31 , 2021.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2021
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates used are those related to stock-based compensation, asset impairments, the valuation and useful lives of depreciable tangible and certain intangible assets, the fair value of common stock used in acquisitions of businesses, the fair value of assets and liabilities acquired in acquisitions of businesses, the fair value of options issued with related party debt, and the valuation allowance of deferred tax assets. Management believes that these estimates are reasonable; however, actual results may differ from these estimates. Accounts Receivable, Allowance for Doubtful Accounts and Concentrations Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate. As of June 30, 2021, and December 31, 2020, we recorded an allowance for doubtful accounts of $ 29,986 and $ 33,848 , respectively. Goodwill and Intangible Assets Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit’s carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit. Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, non-compete agreements, and software development costs. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one to twenty years . No significant residual value is estimated for intangible assets. Software Development Costs Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the FASB guidance for the costs of computer software to be sold, leased, or otherwise marketed (“ASC Subtopic 985-20”). Software development costs are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable. Technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Software development costs are capitalized once technological feasibility of a product is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated on a project-by-project basis. Amounts related to software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are cancelled or abandoned are charged to product development expense in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four month period. The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer. Impairment of Long-Lived Assets We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate. Foreign Currency Translation The Company translates the financial statements of its foreign subsidiary from the local (functional) currency into US Dollars using the year or reporting period end or average exchange rates in accordance with the requirements of Accounting Standards Codification subtopic 830-10, Foreign Currency Matters (“ASC 830-10”) . Assets and liabilities of these subsidiaries were translated at exchange rates as of the balance sheet date. Revenues and expenses are translated at average rates in effect for the periods presented. The cumulative translation adjustment is included in the accumulated other comprehensive gain (loss) within shareholders’ equity. Foreign currency transaction gains and losses arising from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the unaudited Condensed Consolidated Statements of Income and Comprehensive Income. Revenue Recognition and Concentrations Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting. Some customers are billed on a month-to-month basis with no contractual term and are collected by credit card. Revenue is recognized at the time that the services are rendered, and the selling price is fixed with a set range of plans. Cash received in advance of the performance of services is recorded as deferred revenue. Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Accounting Standards Codification 606 (“ASC 606”), is a comprehensive revenue recognition standard that superseded nearly all existing revenue recognition guidance. The Company adopted this standard effective January 1, 2018, applying the modified retrospective method. Upon adoption, the Company discontinued revenue deferral under the sell-through model and commenced recording revenue upon delivery to distributors, net of estimated returns. Generally, the new standard results in earlier recognition of revenues. We determine revenue recognition under ASC 606 through the following steps:  identification of the contract, or contracts, with a customer;  identification of the performance obligations in the contract;  identification of the transaction price;  allocation of the transaction price to the performance obligations in the contract; and  recognition of revenue when, or as, we satisfy a performance obligation. During the six months ended June 30, 2021 and 2020, two customers accounted for 66 % and 71 % of our revenues, respectively. Comprehensive Income (Loss) Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We are required to record all components of comprehensive loss in the consolidated financial statements in the period in which they are recognized. Net loss and other comprehensive loss, including foreign currency translation adjustments and unrealized gains and losses on investments, are reported, net of their related tax effect, to arrive at comprehensive loss. For the six months ended June 30, 2021 and 2020, the comprehensive loss was $ 3,145,238 and $ 1,780,605 respectively. Net Loss Per Common Share Basic net loss per share excludes any dilutive effects of options, shares subject to repurchase and warrants. Diluted net loss per share includes the impact of potentially dilutive securities. During the three and six months ended June 30, 2021 and 2020, we had securities outstanding which could potentially dilute basic earnings per share in the future. Those were excluded from the computation of diluted net loss per share when their effect would have been anti-dilutive. Reclassifications Certain amounts from prior periods have been reclassified to conform to the current period presentation. Recent Accounting Pronouncements Accounting standards promulgated by the FASB are subject to change. Changes in such standards may have an impact on the Company’s future financial statements. The following are a summary of recent accounting developments. In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment, which removes the second step of the two-step goodwill impairment test. Under ASU 2017-04, an entity will apply a one-step quantitative test and record the amount of goodwill impairment as the excess of a reporting unit’s carrying amount over its fair value, not to exceed the total amount of goodwill allocated to the reporting unit. ASU 2017-04 does not amend the optional qualitative assessment of goodwill impairment. Additionally, an entity should consider income tax effects from any tax-deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. ASU 2017-04 is effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019; early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company adopted this standard as of January 1, 2020.

Goodwill and Purchased Intangib

Goodwill and Purchased Intangibles	6 Months Ended
	Jun. 30, 2021
Goodwill and Purchased Intangibles [Abstract]
Goodwill and Purchased Intangibles	3. Goodwill and Purchased Intangibles Goodwill The carrying value of goodwill at June 30, 2021 and December 31, 2020 was $ 496,352 . The following table presents details of our purchased intangible assets as of June 30, 2021 and December 31, 2020: Intangible assets Balance at December 31, 2020 Additions Impairments Amortization Fx and Other Balance at June 30, 2021 Patents and trademarks $ 71,029 $ — $ ( 8,286 ) $ ( 2,705 ) $ 2 $ 60,040 Customer and merchant relationships 642,385 — — ( 48,425 ) — 593,960 Trade name 41,444 — — ( 4,530 ) — 36,914 Acquired technology 128,491 — — ( 8,150 ) — 120,341 Non-compete agreements 45,071 — — ( 7,930 ) — 37,141 $ 928,420 $ — $ ( 8,286 ) $ ( 71,740 ) $ 2 $ 848,396 The intangible assets are being amortized on a straight-line basis over their estimated useful lives of one to twenty years . Amortization expense for intangible assets was $ 35,736 and $ 37,767 for the three months ended June 30, 2021 and 2020, respectively. Amortization expense for intangible assets was $ 71,740 and $ 75,444 for the six months ended June 30, 2021 and 2020, respectively. The estimated future amortization expense of our intangible assets as of June 30, 2021 is as follows: Year ending December 31, Amount 2021 $ 74,057 2022 148,114 2023 145,606 2024 109,009 2025 101,261 Thereafter 270,349 Total $ 848,396

Software Development Costs

Software Development Costs	6 Months Ended
	Jun. 30, 2021
Software Development Costs [Abstract]
Software Development Costs	4. Software Development Costs The Company has capitalized certain costs for software developed or obtained for internal use during the application development stage as it relates to specific contracts. The amounts capitalized include external direct costs of services used in developing internal-use software and for payroll and payroll-related costs of employees directly associated with the development activities The following table presents details of our software development costs as of June 30, 2021 and December 31, 2020: Balance at December 31, 2020 Additions Amortization Balance at June 30, 2021 Software Development Costs $ 439,908 $ 190,699 $ ( 204,748 ) $ 425,859 $ 439,908 $ 190,699 $ ( 204,748 ) $ 425,859 Software development costs are being amortized on a straight-line basis over their estimated useful life of two years . Amortization expense for software development costs was $ 105,539 and $130, 803 for the three months ended June 30, 2021 and 2020, respectively. Amortization expense for software development costs was $ 204,748 and $ 261,015 for the six months ended June 30, 2021 and 2020, respectively. The estimated future amortization expense of software development costs as of June 30, 2021 is as follows: Year ending December 31, Amount 2021 $ 194,888 2022 189,605 2023 41,366 2024 — 2025 — Thereafter — Total $ 425,859

Operating Lease Assets

Operating Lease Assets	6 Months Ended
	Jun. 30, 2021
Operating Lease Assets [Abstract]
Operating Lease Assets	5. Operating Lease Assets The Company entered into a lease agreement on February 1, 2021 for 8,898 square feet, for its office facilities in Chandler, AZ through January 2027. Monthly rental payments, excluding common area maintenance charges, are $ 25,953 to $ 28,733 . The first twelve months of the lease includes a 50 % abatement period and a deposit for $ 110,000 was required. The lessor contributed $ 110,000 towards the purchase of office furniture as part of the lease agreement. As of June 30, 2021, we have an operating lease asset balance of $ 1,296,574 and an operating lease liability balance of $ 1,467,086 recorded in accordance with ASC 842. The following are additional details related to leases recorded on our balance sheet as of June 30, 2021: Leases Classification Balance at June 30, 2021 Assets Noncurrent Operating lease assets Noncurrent operating lease assets $ 1,296,574 Total lease assets $ 1,296,574 Liabilities Current Operating lease liabilities Operating lease liabilities $ 161,867 Noncurrent Operating lease liabilities Noncurrent operating lease liabilities $ 1,305,219 Total lease liabilities $ 1,467,086 The maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases, a reconciliation to operating lease liabilities reported on the Condensed Consolidated Balance Sheet, our weighted-average remaining lease term and weighted average discount rate: Year ending December 31, Amount 2021 $ 98,083 2022 318,055 2023 324,220 2024 330,894 2025 337,568 Thereafter 372,976 Total future lease payments 1,781,796 Less: imputed interest ( 314,710 ) Total $ 1,467,086 Weighted Average Remaining Lease Term (years) Operating leases 5.2 Weighted Average Discount Rate Operating leases 6.75 %

Notes Payable and Interest Expe

Notes Payable and Interest Expense	6 Months Ended
	Jun. 30, 2021
Notes Payable and Interest Expense [Abstract]
Notes Payable and Interest Expense	6. Notes Payable and Interest Expense The following table presents details of our notes payable as of June 30, 2021 and December 31, 2020: Facility Maturity Interest Rate Balance at June 30, 2021 Balance at December 31, 2020 BDC Term Loan October 15, 2021 23.5 % $ 111,318 $ 160,088 ACOA Note February 1, 2024 — 97,601 111,430 Wintrust Bank November 14, 2021 Prime + 1.5 % — 366,667 TD Bank December 31, 2022 — 32,266 31,390 Chase Bank April 10, 2022 1 % 891,103 891,102 Related Party Note - Net June 30, 2024 15 % 1,704,647 580,000 Total Debt 2,836,935 2,140,677 Less current portion ( 149,634 ) ( 641,676 ) Long-term debt, net of current portion $ 2,687,301 $ 1,499,001 BDC Term Loan On January 8, 2016, Livelenz, a wholly-owned subsidiary of the Company (“Livelenz”), entered into an amendment of their original loan agreement dated August 26, 2011 with the Business Development Bank of Canada (“BDC”). Under this agreement the loan would have matured, and the commitments would have terminated on September 15, 2019. On July 26, 2019, Livelenz, entered into an amendment of their original loan agreement dated August 26, 2011 with BDC. Under this agreement the loan will mature, and the commitments will terminate on October 15, 2021 . In accordance with the amendment, the Company will commence monthly payments beginning on August 15, 2019 of principal in the amount of $ 8,500 CAD in addition to the monthly payment of accrued interest. These payments will increase to $ 10,000 CAD on November 15, 2019, $ 12,000 CAD on September 15, 2020, $ 14,000 CAD on March 15, 2021, and $ 16,000 CAD on September 15, 2021 in addition to the monthly interest. During the six months ended June 30, 2021 we repaid $ 48,770 USD of principal. ACOA Note On November 6, 2017, Livelenz (a wholly-owned subsidiary of the Company), entered into an amendment of the original agreement dated December 2, 2014 with the Atlantic Canada Opportunities Agency (“ACOA”). Under this agreement the note will mature, and the commitments will terminate on February 1, 2024 . The monthly principal payment amount of $ 3,000 CAD increased to $ 3,500 CAD beginning on November 1, 2019, $ 4,000 CAD on August 1, 2021, $ 4,500 CAD on August 1, 2022, and $ 2,215 CAD during the remaining term of the agreement. Payments from April-December of 2020 were voluntarily deferred by ACOA due to COVID-19. During the six months ended June 30, 2021 we repaid $ 13,829 USD of principal. Wintrust Loan On November 14, 2018, the Company entered into a Loan and Security Agreement with Wintrust Bank. The Loan and Security Agreement provides for a single-term loan to us in the original principal amount of $ 1,000,000 . Interest accrues on the unpaid principal amount at the rate of prime plus 1.5 %. The loan is a three-year loan and is interest-only payable for the first six months of the loan. Commencing on May 1, 2019, the Company will commence monthly payments of principal in the amount of $ 33,333 in addition to the monthly payment of accrued interest. The loan is secured by all of our assets other than our intellectual property. We used the proceeds of the loan to re-finance a loan in the principal amount of $ 1,000,000 we assumed as part of the acquisition of the Belly assets. On August 7, 2020, the Company entered into an amendment of their original loan agreement dated November 14, 2018 with Wintrust Bank. Under this agreement the covenant calculation was amended to calculate covenants under a borrowing base methodology. The Company had defaulted under the March 31, 2020 and June 30, 2020 covenants which were waived upon execution of the amendment and the Company has not committed any defaults under loan agreement subsequent to the amendment. During the six months ended June 30, 2021 we repaid $ 366,667 of principal and thereby paid the loan in full. The Company’s assets securing the loan are now free from any liens under the Wintrust Loan and Security Agreement as of June 30, 2021. Chase Loan On April 10, 2020, we entered into a commitment loan with Chase Bank, N.A. under the CARES act and the Small Business Administration (SBA) Paycheck Protection Program (PPP), in the principal aggregate amount of $ 891,102 , which is due and payable two years after issuance. This note bears interest on the unpaid balance at the rate of one percent ( 1 %) per annum. The note contains a deferral period of ten months after the 24 week usage period, for which no interest or principal payments are due. Forgiveness of the loan may be obtained by meeting certain SBA requirements. On July 21, 2021, SBA has authorized full forgiveness of the $ 891,102 PPP Loan after the Company applied for a loan forgiveness and met all the requirements for such loan forgiveness under the SBA program. TD Bank Loan On April 22, 2020, we entered into a commitment loan with TD Bank under the Canadian Emergency Business Account (“CEBA”), in the principal aggregate amount of $ 40,000 CAD, which is due and payable on December 31, 2022. This note bears interest on the unpaid balance at the rate of zero percent ( 0 %) per annum during the initial term. Under this note no interest or principal payments are due until January 1, 2023. Under the conditions of the loan, twenty-five percent ( 25 %) of the loan will be forgiven if seventy-five percent ( 75 %) is repaid prior to the initial term date. Related Party Notes During February 2018, we conducted a private placement of Unsecured Promissory Notes (individually, a “Note” and collectively, the “Notes”) in the aggregate principal amount of $ 1,080,000 to certain investors, officers and directors of the Company. Each Note bears interest on the unpaid balance at the rate of fifteen percent ( 15 %) per annum and the principal and accrued interest is due and payable no later than December 1, 2020. We may prepay any of the Notes without notice, subject to a two percent ( 2 %) pre-payment penalty. The Note offer was conducted by our management and there were no commissions paid by us in connection with the solicitation. On February 26, 2020, we issued an unsecured Note in the principle aggregate amount of $ 200,000 , which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of fifteen percent ( 15 %) per annum. The Company may prepay this Note without notice, subject to a two percent ( 2 %) pre-payment penalty. On November 18, 2020, we issued two additional unsecured Notes in the principle aggregate amount of $ 500,000 , which becomes due two years after the date of issuance. These Notes bear interest on the unpaid balance at the rate of fifteen percent ( 15 %) per annum. The Company may prepay these Notes without notice, subject to a two percent ( 2 %) pre-payment penalty. On December 31, 2020 $ 1,200,000 of these Notes and the accrued interest of $ 192,208 was settled into equity. We recorded a loss on settlement of debt of $ 668,260 for the year ended December 31, 2020. On January 25, 2021, we repaid $ 65,000 for an unsecured Note. On January 27, 2021, we repaid the remaining $ 15,000 of the unsecured Note and accrued interest of $ 34,379 . On June 30, 2021, we entered into a Credit Facility Agreement (the “Credit Agreement”) with one of the Company’s directors. The Company can borrow up to $ 2,000,000 under this Credit Agreement and has drawn a total of $ 1,823,750 during the period, including cash in the amount of $ 1,280,000 and 543,750 of principal and accrued interest under the above-described Notes that was rolled into the Credit Facility. The loan is secured by all our tangible and intangible assets including intellectual property. We will repay the principal amount plus accrued interest in 24 equal monthly installments commencing on June 30, 2022 and ending on June 30, 2024. This loan bears interest on unpaid balance at the rate of fifteen percent ( 15 %) per annum. The Company may prepay this Note without notice, penalty or charge. In consideration of the lender’s agreement to provide the facility, the Company issued warrants to purchase shares of its common stock at an exercise price of $ 1.67 per share in connection with the issuance of funds under this Credit Agreement. The warrants are exercisable for a period commencing upon issuance of the notes and ending 36 months after issuance of the financing. In addition, the Company has agreed to issue to the lender additional warrants entitling the lender to purchase a number of shares of the Company common stock equal to ten percent ( 10 %) of the amount of the advances made divided by the volume weighted average price over the 30 trading days preceding the advance (VWAP). Each warrant will be exercisable over a three-year period at an exercise price equal to the VWAP. During the six months period ending June 30, 2021, the Company issued warrants to purchase an aggregate of 227,994 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement. The estimated aggregate fair value of the warrants issued is $ 119,103 using the Black-Scholes option valuation model as of June 30, 2021. As of June 30, 2021, we have a principal balance of $ 1,823,750 , discount of $ 119,103 , and accrued interest of $ 0 outstanding under the said Credit Agreement. Interest Expense Interest expense was $ 23,867 and $ 68,088 during the three months ended June 30, 2021 and 2020, respectively. Interest expense was $ 56,383 and $ 145,277 during the six months ended June 30, 2021 and 2020, respectively.

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jun. 30, 2021
Stockholders' Equity [Abstract]
Stockholders' Equity	7. Stockholders’ Equity Common Stock 2020 On March 2, 2020, the Company issued 234,500 shares of common stock in exchange for cash in conjunction with a warrant exercise. The shares were exercised at the strike price of $ 1.00 per share. On September 17, 2020, the Company issued 15,000 shares of common stock in exchange for cash in conjunction with a stock option exercise. The shares were exercised at the strike price of $ 0.48 per share. In December of 2020, the Company commenced a private placement of its common stock with warrant exercises for one unit of our common stock at an exercise price of $ 1.25 per share to receive a new warrant to purchase to one share of our common stock at an exercise price of $ 2.00 per share. As of December 31, 2020, the Company had sold 2,666,459 units of its common stock for gross proceeds of $ 3,333,074 . In addition, the Company issued 1,113,767 units of its common stock associated with the settlement of $ 1,200,000 of principal, $ 192,208 of accrued interest, and a loss on settlement of $ 668,260 (See Note 6). During 2020, the Company recorded stock-based compensation expense of $ 260,003 related to restricted stock units for members of our board of directors. As of December 31, 2020 we had an equity payable balance of $ 100,862 . 2021 During the six months ended June 30, 2021, the Company recorded stock-based compensation expense of $ 130,005 related to restricted stock units for members of our board of directors. In addition, we also recorded $ 59,712 of stock-based compensation expense related to restricted stock units as employee compensation. As of June 30, 2021 we had an equity payable balance of $ 100,862 . Stock-based Plans Stock Option Activity The following table summarizes stock option activity for the year ended December 31, 2020 and for the six months ended June 30, 2021: Options Outstanding at December 31, 2019 5,781,884 Granted 1,545,000 Exercised ( 15,000 ) Forfeit/canceled ( 814,068 ) Expired ( 490,264 ) Outstanding at December 31, 2020 6,007,552 Granted 87,500 Exercised — Forfeit/canceled ( 76,406 ) Expired ( 92,180 ) Outstanding at June 30, 2021 5,926,466 The weighted average exercise price of stock options granted during the period was $ 1.80 and the related weighted average grant date fair value was $ 1.16 per share. 2020 On March 24, 2020, the Company granted one employee a total of 15,000 options to purchase shares of the Company common stock at the closing price as of March 24, 2020 of $ 0.65 per share. The option shares will vest 25 % on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until March 24, 2030. The total estimated value using the Black-Scholes Model, based on a volatility rate of 77.56 % and an option fair value of $ 0.43 was $ 6,472 . On April 6, 2020, the Company granted four employees a total of 700,000 options to purchase shares of the Company common stock at the closing price as of April 6, 2020 of $ 0.70 per share. 500,000 option shares will vest 25 % on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until April 6, 2030. 200,000 option shares will vest ratably over forty-eight ( 48 ) months and are exercisable until April 6, 2030. The total estimated value using the Black-Scholes Model, based on a volatility rate of 78.21 % and an option fair value of $ 0.47 was $ 326,752 . On November 5, 2020, the Company granted one employee a total of 20,000 options to purchase shares of the Company common stock at the closing price as of November 5, 2020 of $ 0.96 per share. The option shares will vest 25 % on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until November 5, 2030. The total estimated value using the Black-Scholes Model, based on a volatility rate of 77.36 % and an option fair value of $ 0.63 was $ 12,689 . On December 7, 2020, the Company granted one employee a total of 600,000 options to purchase shares of the Company common stock at the closing price as of December 7, 2020 of $ 1.55 per share. The option shares will vest 25 % on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until December 7, 2030. The total estimated value using the Black-Scholes Model, based on a volatility rate of 77.35 % and an option fair value of $ 1.03 was $ 615,495 . On December 17, 2020, the Company granted six employees a total of 210,000 options to purchase shares of the Company common stock at the closing price as of December 17, 2020 of $ 1.83 per share. The option shares will vest 25 % on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until December 17, 2030. The total estimated value using the Black-Scholes Model, based on a volatility rate of 77.41 % and an option fair value of $ 1.21 was $ 254,373 . 2021 On March 26, 2021, the Company granted five employees a total of 67,500 options to purchase shares of the Company common stock at the closing price as of March 26, 2021 of $ 1.80 per share. The option shares will vest 25 % on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until March 26, 2031. The total estimated value using the Black-Scholes Model, based on a volatility rate of 73.97 % and an option fair value of $ 1.16 was $ 78,492 . On May 2, 2021, the Company granted one employee a total of 20,000 options to purchase shares of the Company common stock at the closing price as of May 2, 2021, of $ 1.48 per share. The option shares will vest 25 % on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until May 2, 2031. The total estimated value using the Black-Scholes Model, based on a volatility rate of 74.79 % and an option fair value of $ 0.93 was $ 18,628 . Stock-Based Compensation Expense from Stock Options and Warrants The impact on our results of operations of recording stock-based compensation expense for the three and six months ended June 30, 2021 and 2020 were as follows: Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 General and administrative $ 79,758 $ 58,149 $ 163,888 $ 136,698 Sales and marketing 31,068 20,921 63,813 34,598 Engineering, research, and development 43,606 44,474 86,658 86,461 $ 154,432 $ 123,544 $ 314,359 $ 257,757 Valuation Assumptions The fair value of each stock option award was calculated on the date of grant using the Black-Scholes option pricing model. The following weighted average assumptions were used for the six months ended June 30, 2021 and 2020. Six Months Ended June 30, 2021 2020 Risk-free interest rate 1.01 % 0.58 % Expected life (years) 6.00 6.00 Expected dividend yield — % — % Expected volatility 74.16 % 77.57 % The risk-free interest rate assumption is based upon published interest rates appropriate for the expected life of our employee stock options. The expected life of the stock options represents the weighted-average period that the stock options are expected to remain outstanding and was determined based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and expectations of future employee behavior as influenced by changes to the terms of its stock-based awards. The dividend yield assumption is based on our history of not paying dividends and no future expectations of dividend payouts. The expected volatility in 2021 and 2020 is based on the historical publicly traded price of our common stock. Restricted stock units The following table summarizes restricted stock unit activity under our stock-based plans for the year ended December 31, 2020 and for the six months ended June 30, 2021: Shares Outstanding at December 31, 2019 1,152,248 Awarded 284,480 Released — Canceled/forfeited/expired — Outstanding at December 31, 2020 1,436,728 Awarded 575,036 Released — Canceled/forfeited/expired — Outstanding at June 30, 2021 2,011,764 Expected to vest at June 30, 2021 2,011,764 Vested at June 30, 2021 1,543,014 Unvested at June 30, 2021 — Unrecognized expense at June 30, 2021 $ — 2020 On March 24, 2020, the Company issued to four independent directors a total of 100,000 restricted stock units. These restricted stock units were issued for the $ 65,000 of board compensation earned for the first quarter of 2020. The units were valued at $ 65,000 or $ 0.65 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) March 24, 2023, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. On August 7, 2020, the Company granted four independent directors a total of 81,252 restricted stock units. The units were valued at $ 65,000 or $ 0.80 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) August 7, 2023, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. On November 5, 2020, the Company granted four independent directors a total of 67,708 restricted stock units. The units were valued at $ 65,000 or $ 0.96 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) November 5, 2023, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. On December 17, 2020, the Company granted four independent directors a total of 35,520 restricted stock units. The units were valued at $ 65,000 or $ 1.83 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) December 17, 2023, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. In the twelve months ended December 31, 2020, the company recorded $ 260,003 in restricted stock units as board compensation. 2021 On March 26, 2021, the Company issued to four independent directors a total of 36,112 restricted stock units. These restricted stock units were issued for the $ 65,000 of board compensation earned for the first quarter of 2021. The units were valued at $ 65,002 or $ 1.80 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) March 26, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. On March 26, 2021, the Company granted to one employee 1,000,000 restricted shares of the Company’s Common Stock at the closing price as of March 26, 2021 of $ 1.80 per share. The restricted stock will vest as follows (a) 50 % of the restricted shares will vest ratably over forty-eight ( 48 ) months; (b) 15 % of the restricted shares will vest upon the Company achieving $ 25,000,000 in annualized recurring revenues as reported by totaling all contracted revenues for the trailing twelve months following the end of a reporting quarter; (c) the final 35 % of the restricted shares will vest upon the Company achieving $ 50,000,000 in annualized recurring revenues as reported by totaling all contracted revenues for the trailing twelve months following the end of a reporting quarter. Vesting is dependent on the employee’s continued employment with the Company. All of the 1,000,000 restricted shares will include a single trigger accelerated vesting should the Company undergo a change of control after August 1, 2021. If the Company undergoes a change of control prior to August 1, 2021, 300,000 of the restricted shares would be eligible for single trigger accelerated vesting. On May 12, 2021, the Company issued to four independent directors a total of 38,924 restricted stock units. These restricted stock units were issued for the $ 65,000 of board compensation earned for the second quarter of 2021. The units were valued at $ 65,002 or $ 1.67 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) May 2, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. In the six months ended June 30, 2021, the company recorded $ 130,005 in restricted stock units as board compensation and $ 59,712 as employee compensation. Stock Based Compensation from Restricted Stock The impact on our results of operations of recording stock-based compensation expense for restricted stock units for the three and six months ended June 30, 2021 and 2020 was as follows: Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 General and administrative $ 65,003 $ — $ 130,005 $ 65,000 Sales and marketing $ 56,018 $ — $ 59,712 $ — $ 121,021 $ — $ 189,717 $ 65,000 As of June 30, 2021, there was no unearned restricted stock unit compensation. Warrants 2020 On March 2, 2020 one warrant holder exercised their common stock purchase warrant for 234,500 shares at the exercise price of $ 1.00 per share, resulting in additional capital of $ 234,500 . In December 2020, warrant holders exercised warrants to purchase common stock at $ 1.25 per share. At the commencement of the December warrant exercise, there were warrants outstanding that entitled their holders to purchase 2,691,459 shares of our common stock at exercise prices of $ 1.25 per share. Pursuant to the offer, warrant holders exercised warrants to purchase 2,666,459 shares of our common stock, resulting in additional capital of $ 3,333,074 . As part of the exercise, 2,666,459 new warrants were issued to purchase common stock at $ 2.00 per share within three years. 2021 On June 30, 2021, the company issued warrants to purchase an aggregate of 227,994 shares of its common stock at an exercise price of $ 1.67 per share for 119,760 inducement warrants and VWAP for 108,234 additional warrants in connection with the issuance of a loan by a related party. The warrants are exercisable for a period commencing upon issuance of the notes and ending 36 months after issuance of the financing. The estimated aggregate fair value of the warrants issued is $ 119,103 using the Black-Scholes option valuation model. As of June 30, 2021, we have outstanding warrants to purchase 25,000 shares of Common Stock at $ 1.25 per share in addition to warrants to purchase 2,666,459 shares of common stock at $ 2.00 per share. These warrants expire in 2021 and 2023, respectively. We also have outstanding warrants to purchase 227,994 shares of common stock at stated price per share in connection with the issuance of a loan with a related party. These warrants expire in 2024.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2021
Fair Value Measurements [Abstract]
Fair Value Measurements	8. Fair Value Measurements Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the authoritative guidance establishes a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs other than the quoted prices in active markets that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which requires us to develop our own assumptions. This hierarchy requires companies to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. On a recurring basis, we measure certain financial assets and liabilities at fair value. The following table presents assets that are measured and recognized at fair value as of March 31, 2021 on a recurring and non-recurring basis: Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ — $ — $ 496,352 $ — Intangibles, net (non-recurring) $ — $ — $ 1,274,255 $ — The following table presents assets that are measured and recognized at fair value as of December 31, 2020 on a recurring and non-recurring basis: Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ — $ — $ 496,352 $ — Intangibles, net (non-recurring) $ — $ — $ 1,368,329 $ —

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2021
Commitments and Contingencies [Abstract]
Commitments and Contingencies	9. Commitments and Contingencies Litigation As of the date of this report, there are no pending legal proceedings to which we or our properties are subject, except for routine litigation incurred in the normal course of business. Operating Lease As described in Note 5, the Company has a lease agreement for 8,898 square feet, for its office facilities in Chandler, AZ through January 2027. Monthly rental payments, excluding common area maintenance charges, are $ 25,953 to $ 28,733 . The first twelve months of the lease includes a 50 % abatement period. As of June 30, 2021, we have an operating lease asset balance for this lease of $ 1,271,016 and an operating lease liability balance for this lease of $ 1,434,397 recorded in accordance with ASC 842 The Company also has a lease through April 2022 for 3,248 square feet of office space located in Halifax, Nova Scotia, at a monthly rental expense of $ 2,665 to $ 3,371 per month, excluding common area maintenance charges. As of June 30, 2021, we have an operating lease asset balance for this lease of $ 25,559 and an operating lease liability balance for this lease of $ 36,690 recorded in accordance with ASC 842.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2021
Related Party Transactions [Abstract]
Related Party Transactions	10. Related Party Transactions Unsecured Promissory Note Investments 2020 During February 2018, we conducted a private placement of Unsecured Promissory Notes (individually, a “ Note ” and collectively, the “ Notes ”) in the aggregate principal amount of $ 1,080,000 to certain investors, officers and directors of the Company. Each Note bears interest on the unpaid balance at the rate of fifteen percent ( 15 %) per annum and the principal and accrued interest is due and payable no later than December 1, 2020. We may prepay any of the Notes without notice, subject to a two percent ( 2 %) pre-payment penalty. The Note offer was conducted by our management and there were no commissions paid by us in connection with the solicitation. On February 26, 2020, we issued an unsecured Note in the principle aggregate amount of $ 200,000 , which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of fifteen percent ( 15 %) per annum. The Company may prepay this Note without notice, subject to a two percent ( 2 %) pre-payment penalty. On November 18, 2020, we issued two additional unsecured Notes in the principle aggregate amount of $ 500,000 , which becomes due two years after the date of issuance. These Notes bear interest on the unpaid balance at the rate of fifteen percent ( 15 %) per annum. The Company may prepay these Notes without notice, subject to a two percent ( 2 %) pre-payment penalty. On December 31, 2020 $ 1,200,000 of these Notes and the accrued interest of $ 192,208 was settled into equity. We recorded a loss on settlement of debt of $ 668,260 for the year ended December 31, 2020. 2021 On January 25, 2021, we repaid $ 65,000 for an unsecured Note. On January 27, 2021, we repaid the remaining $ 15,000 of the unsecured Note and accrued interest of $ 34,379 . On June 30, 2021, we entered into a Credit Facility Agreement (the “Credit Agreement”) with one of the Company’s directors. The Company can borrow up to $ 2,000,000 under this Credit Agreement and has drawn a total of $ 1,823,750 during the period, including cash in the amount of $ 1,280,000 and 543,750 of principal and accrued interest under the above-described Notes that was rolled into the Credit Facility. The loan is secured by all our tangible and intangible assets including intellectual property. We will repay the principal amount plus accrued interest in 24 equal monthly installments commencing on June 30, 2022 and ending on June 30, 2024. This loan bears interest on unpaid balance at the rate of fifteen percent ( 15 %) per annum. The Company may prepay this Note without notice, penalty or charge. In consideration of the lender’s agreement to provide the facility, the Company issued warrants to purchase shares of its common stock at an exercise price of $ 1.67 per share in connection with the issuance of funds under this Credit Agreement. The warrants are exercisable for a period commencing upon issuance of the notes and ending 36 months after issuance of the financing. In addition, the Company has agreed to issue to the lender additional warrants entitling the lender to purchase a number of shares of the Company common stock equal to ten percent ( 10 %) of the amount of the advances made divided by the volume weighted average price over the 30 trading days preceding the advance (VWAP). Each warrant will be exercisable over a three-year period at an exercise price equal to the VWAP. During the six months period ending June 30, 2021, the Company issued warrants to purchase an aggregate of 227,994 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement. The estimated aggregate fair value of the warrants issued is $ 119,103 using the Black-Scholes option valuation model as of June 30, 2021. As of June 30, 2021, we have a principal balance of $ 1,823,750 , discount of $ 119,103 , and accrued interest of $ 0 outstanding under the said Credit Agreement.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	11. Subsequent Events On July 21, 2021, the SBA authorized full forgiveness of the $ 891,102 PPP Loan after the Company applied for a loan forgiveness and met all the requirements for such loan forgiveness under the SBA program.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policy)	6 Months Ended
	Jun. 30, 2021
Summary of Significant Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates used are those related to stock-based compensation, asset impairments, the valuation and useful lives of depreciable tangible and certain intangible assets, the fair value of common stock used in acquisitions of businesses, the fair value of assets and liabilities acquired in acquisitions of businesses, the fair value of options issued with related party debt, and the valuation allowance of deferred tax assets. Management believes that these estimates are reasonable; however, actual results may differ from these estimates.
Accounts Receivable, Allowance for Doubtful Accounts and Concentrations	Accounts Receivable, Allowance for Doubtful Accounts and Concentrations Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate. As of June 30, 2021, and December 31, 2020, we recorded an allowance for doubtful accounts of $ 29,986 and $ 33,848 , respectively.
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit’s carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit. Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, non-compete agreements, and software development costs. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one to twenty years . No significant residual value is estimated for intangible assets.
Software Development Costs	Software Development Costs Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the FASB guidance for the costs of computer software to be sold, leased, or otherwise marketed (“ASC Subtopic 985-20”). Software development costs are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable. Technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Software development costs are capitalized once technological feasibility of a product is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated on a project-by-project basis. Amounts related to software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are cancelled or abandoned are charged to product development expense in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four month period. The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate.
Foreign Currency Translation	Foreign Currency Translation The Company translates the financial statements of its foreign subsidiary from the local (functional) currency into US Dollars using the year or reporting period end or average exchange rates in accordance with the requirements of Accounting Standards Codification subtopic 830-10, Foreign Currency Matters (“ASC 830-10”) . Assets and liabilities of these subsidiaries were translated at exchange rates as of the balance sheet date. Revenues and expenses are translated at average rates in effect for the periods presented. The cumulative translation adjustment is included in the accumulated other comprehensive gain (loss) within shareholders’ equity. Foreign currency transaction gains and losses arising from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the unaudited Condensed Consolidated Statements of Income and Comprehensive Income.
Revenue Recognition and Concentrations	Revenue Recognition and Concentrations Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting. Some customers are billed on a month-to-month basis with no contractual term and are collected by credit card. Revenue is recognized at the time that the services are rendered, and the selling price is fixed with a set range of plans. Cash received in advance of the performance of services is recorded as deferred revenue. Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Accounting Standards Codification 606 (“ASC 606”), is a comprehensive revenue recognition standard that superseded nearly all existing revenue recognition guidance. The Company adopted this standard effective January 1, 2018, applying the modified retrospective method. Upon adoption, the Company discontinued revenue deferral under the sell-through model and commenced recording revenue upon delivery to distributors, net of estimated returns. Generally, the new standard results in earlier recognition of revenues. We determine revenue recognition under ASC 606 through the following steps:  identification of the contract, or contracts, with a customer;  identification of the performance obligations in the contract;  identification of the transaction price;  allocation of the transaction price to the performance obligations in the contract; and  recognition of revenue when, or as, we satisfy a performance obligation. During the six months ended June 30, 2021 and 2020, two customers accounted for 66 % and 71 % of our revenues, respectively.
Comprehensive Income (Loss)	Comprehensive Income (Loss) Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We are required to record all components of comprehensive loss in the consolidated financial statements in the period in which they are recognized. Net loss and other comprehensive loss, including foreign currency translation adjustments and unrealized gains and losses on investments, are reported, net of their related tax effect, to arrive at comprehensive loss. For the six months ended June 30, 2021 and 2020, the comprehensive loss was $ 3,145,238 and $ 1,780,605 respectively.
Net Loss Per Common Share	Net Loss Per Common Share Basic net loss per share excludes any dilutive effects of options, shares subject to repurchase and warrants. Diluted net loss per share includes the impact of potentially dilutive securities. During the three and six months ended June 30, 2021 and 2020, we had securities outstanding which could potentially dilute basic earnings per share in the future. Those were excluded from the computation of diluted net loss per share when their effect would have been anti-dilutive.
Reclassifications	Reclassifications Certain amounts from prior periods have been reclassified to conform to the current period presentation.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Accounting standards promulgated by the FASB are subject to change. Changes in such standards may have an impact on the Company’s future financial statements. The following are a summary of recent accounting developments. In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment, which removes the second step of the two-step goodwill impairment test. Under ASU 2017-04, an entity will apply a one-step quantitative test and record the amount of goodwill impairment as the excess of a reporting unit’s carrying amount over its fair value, not to exceed the total amount of goodwill allocated to the reporting unit. ASU 2017-04 does not amend the optional qualitative assessment of goodwill impairment. Additionally, an entity should consider income tax effects from any tax-deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. ASU 2017-04 is effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019; early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company adopted this standard as of January 1, 2020.

Goodwill and Purchased Intang_2

Goodwill and Purchased Intangibles (Tables)	6 Months Ended
	Jun. 30, 2021
Goodwill and Purchased Intangibles [Abstract]
Intangible Assets	Balance at December 31, 2020 Additions Impairments Amortization Fx and Other Balance at June 30, 2021 Patents and trademarks $ 71,029 $ — $ ( 8,286 ) $ ( 2,705 ) $ 2 $ 60,040 Customer and merchant relationships 642,385 — — ( 48,425 ) — 593,960 Trade name 41,444 — — ( 4,530 ) — 36,914 Acquired technology 128,491 — — ( 8,150 ) — 120,341 Non-compete agreements 45,071 — — ( 7,930 ) — 37,141 $ 928,420 $ — $ ( 8,286 ) $ ( 71,740 ) $ 2 $ 848,396
Future Amortization Intangible Assets	Year ending December 31, Amount 2021 $ 74,057 2022 148,114 2023 145,606 2024 109,009 2025 101,261 Thereafter 270,349 Total $ 848,396

Software Development Costs (Tab

Software Development Costs (Tables)	6 Months Ended
	Jun. 30, 2021
Software Development Costs [Abstract]
Software Development Costs	Balance at December 31, 2020 Additions Amortization Balance at June 30, 2021 Software Development Costs $ 439,908 $ 190,699 $ ( 204,748 ) $ 425,859 $ 439,908 $ 190,699 $ ( 204,748 ) $ 425,859
Future Amortization of Software	Year ending December 31, Amount 2021 $ 194,888 2022 189,605 2023 41,366 2024 — 2025 — Thereafter — Total $ 425,859

Operating Lease Assets (Tables)

Operating Lease Assets (Tables)	6 Months Ended
	Jun. 30, 2021
Operating Lease Assets [Abstract]
Additional Details Related to Leases on Balance Sheet	Leases Classification Balance at June 30, 2021 Assets Noncurrent Operating lease assets Noncurrent operating lease assets $ 1,296,574 Total lease assets $ 1,296,574 Liabilities Current Operating lease liabilities Operating lease liabilities $ 161,867 Noncurrent Operating lease liabilities Noncurrent operating lease liabilities $ 1,305,219 Total lease liabilities $ 1,467,086
Schedule of Minimum Lease Payments Including Weighted-Average Remaining Lease Term and Discount Rates	The maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases, a reconciliation to operating lease liabilities reported on the Condensed Consolidated Balance Sheet, our weighted-average remaining lease term and weighted average discount rate: Year ending December 31, Amount 2021 $ 98,083 2022 318,055 2023 324,220 2024 330,894 2025 337,568 Thereafter 372,976 Total future lease payments 1,781,796 Less: imputed interest ( 314,710 ) Total $ 1,467,086 Weighted Average Remaining Lease Term (years) Operating leases 5.2 Weighted Average Discount Rate Operating leases 6.75 %

Notes Payable and Interest Ex_2

Notes Payable and Interest Expense (Tables)	6 Months Ended
	Jun. 30, 2021
Notes Payable and Interest Expense [Abstract]
Schedule of Notes Payable	Facility Maturity Interest Rate Balance at June 30, 2021 Balance at December 31, 2020 BDC Term Loan October 15, 2021 23.5 % $ 111,318 $ 160,088 ACOA Note February 1, 2024 — 97,601 111,430 Wintrust Bank November 14, 2021 Prime + 1.5 % — 366,667 TD Bank December 31, 2022 — 32,266 31,390 Chase Bank April 10, 2022 1 % 891,103 891,102 Related Party Note - Net June 30, 2024 15 % 1,704,647 580,000 Total Debt 2,836,935 2,140,677 Less current portion ( 149,634 ) ( 641,676 ) Long-term debt, net of current portion $ 2,687,301 $ 1,499,001

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Option Activity	Options Outstanding at December 31, 2019 5,781,884 Granted 1,545,000 Exercised ( 15,000 ) Forfeit/canceled ( 814,068 ) Expired ( 490,264 ) Outstanding at December 31, 2020 6,007,552 Granted 87,500 Exercised — Forfeit/canceled ( 76,406 ) Expired ( 92,180 ) Outstanding at June 30, 2021 5,926,466
Valuation Assumptions	Six Months Ended June 30, 2021 2020 Risk-free interest rate 1.01 % 0.58 % Expected life (years) 6.00 6.00 Expected dividend yield — % — % Expected volatility 74.16 % 77.57 %
Restricted Stock Unit Activity	Shares Outstanding at December 31, 2019 1,152,248 Awarded 284,480 Released — Canceled/forfeited/expired — Outstanding at December 31, 2020 1,436,728 Awarded 575,036 Released — Canceled/forfeited/expired — Outstanding at June 30, 2021 2,011,764 Expected to vest at June 30, 2021 2,011,764 Vested at June 30, 2021 1,543,014 Unvested at June 30, 2021 — Unrecognized expense at June 30, 2021 $ —
Stock Options and Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-Based Compensation Expense	Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 General and administrative $ 79,758 $ 58,149 $ 163,888 $ 136,698 Sales and marketing 31,068 20,921 63,813 34,598 Engineering, research, and development 43,606 44,474 86,658 86,461 $ 154,432 $ 123,544 $ 314,359 $ 257,757
Restricted Stock Units RSU [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-Based Compensation Expense	Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 General and administrative $ 65,003 $ — $ 130,005 $ 65,000 Sales and marketing $ 56,018 $ — $ 59,712 $ — $ 121,021 $ — $ 189,717 $ 65,000

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2021
Fair Value Measurements [Abstract]
Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following table presents assets that are measured and recognized at fair value as of March 31, 2021 on a recurring and non-recurring basis: Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ — $ — $ 496,352 $ — Intangibles, net (non-recurring) $ — $ — $ 1,274,255 $ — The following table presents assets that are measured and recognized at fair value as of December 31, 2020 on a recurring and non-recurring basis: Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ — $ — $ 496,352 $ — Intangibles, net (non-recurring) $ — $ — $ 1,368,329 $ —

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Narrative) (Details)	3 Months Ended		6 Months Ended
	Jun. 30, 2021USD ($)	Jun. 30, 2020USD ($)	Jun. 30, 2021USD ($)customer	Jun. 30, 2020USD ($)	Dec. 31, 2020USD ($)
Product Information [Line Items]
Accounts receivable, allowance for doubtful accounts	$ 29,986		$ 29,986		$ 33,848
Comprehensive loss	$ 1,441,787	$ 751,665	$ 3,145,238	$ 1,780,605
Software Development Costs [Member]
Product Information [Line Items]
Estimated useful lives			2 years
Sales Revenue Net [Member]
Product Information [Line Items]
Number of significant customers | customer			2
Sales Revenue Net [Member] | Customer Concentration Risk [Member] | Two Customers [Member]
Product Information [Line Items]
Customer concentration risk			66.00%	71.00%
Minimum [Member]
Product Information [Line Items]
Estimated useful lives			1 year
Maximum [Member]
Product Information [Line Items]
Estimated useful lives			20 years

Goodwill and Purchased Intang_3

Goodwill and Purchased Intangibles (Narrative) (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Goodwill	$ 496,352		$ 496,352		$ 496,352
Amortization expense	$ 35,736	$ 37,767	$ 71,740	$ 75,444
Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives			1 year
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives			20 years

Goodwill and Purchased Intang_4

Goodwill and Purchased Intangibles (Intangible Assets) (Details)	6 Months Ended
	Jun. 30, 2021USD ($)
Finite-Lived Intangible Assets [Line Items]
Balance at beginning of period	$ 928,420
Impairments	(8,286)
Amortization	(71,740)
Fx and Other	2
Balance at end of period	848,396
Patents and Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Balance at beginning of period	71,029
Impairments	(8,286)
Amortization	(2,705)
Fx and Other	2
Balance at end of period	60,040
Customer and Merchant Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Balance at beginning of period	642,385
Amortization	(48,425)
Balance at end of period	593,960
Trade Name [Member]
Finite-Lived Intangible Assets [Line Items]
Balance at beginning of period	41,444
Amortization	(4,530)
Balance at end of period	36,914
Acquired technology [Member]
Finite-Lived Intangible Assets [Line Items]
Balance at beginning of period	128,491
Amortization	(8,150)
Balance at end of period	120,341
Non-compete Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Balance at beginning of period	45,071
Amortization	(7,930)
Balance at end of period	$ 37,141

Goodwill and Purchased Intang_5

Goodwill and Purchased Intangibles (Future Amortization Intangible Assets) (Details) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Goodwill and Purchased Intangibles [Abstract]
2021	$ 74,057
2022	148,114
2023	145,606
2024	109,009
2025	101,261
Thereafter	270,349
Total	$ 848,396	$ 928,420

Software Development Costs (Nar

Software Development Costs (Narrative) (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 35,736	$ 37,767	$ 71,740	$ 75,444
Software Development Costs [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 105,539		$ 204,748	$ 261,015
Estimated useful lives			2 years

Software Development Costs (Sof

Software Development Costs (Software Development Costs) (Details)	6 Months Ended
	Jun. 30, 2021USD ($)
Finite-Lived Intangible Assets [Line Items]
Balance at beginning of period	$ 439,908
Additions	190,699
Amortization	(204,748)
Balance at end of period	425,859
Software Development Costs [Member]
Finite-Lived Intangible Assets [Line Items]
Balance at beginning of period	439,908
Additions	190,699
Amortization	(204,748)
Balance at end of period	$ 425,859

Software Development Costs (Fut

Software Development Costs (Future Amortization of Software) (Details) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
2021	$ 74,057
2022	148,114
2023	145,606
2024	109,009
2025	101,261
Thereafter	270,349
Total	848,396	$ 928,420
Software Development Costs [Member]
Finite-Lived Intangible Assets [Line Items]
2021	194,888
2022	189,605
2023	41,366
Total	$ 425,859

Operating Lease Assets (Narrati

Operating Lease Assets (Narrative) (Details)	6 Months Ended	12 Months Ended
	Jun. 30, 2021USD ($)ft²	Jan. 31, 2022
Lessee, Lease, Description [Line Items]
Right to use lease assets	$ 1,296,574
Operating lease liability	1,467,086
Fixed assets contributed by lessor	$ 110,000
Lease Starting February 2021 [Member]
Lessee, Lease, Description [Line Items]
Area of office | ft²	8,898
Deposit assets	$ 110,000
Right to use lease assets	1,296,574
Operating lease liability	1,467,086
Fixed assets contributed by lessor	110,000
Lease Starting February 2021 [Member] | Forecast [Member]
Lessee, Lease, Description [Line Items]
Lease abatement percentage		50.00%
Minimum [Member] | Lease Starting February 2021 [Member]
Lessee, Lease, Description [Line Items]
Monthly rental expense	25,953
Maximum [Member] | Lease Starting February 2021 [Member]
Lessee, Lease, Description [Line Items]
Monthly rental expense	$ 28,733

Operating Lease Assets (Additio

Operating Lease Assets (Additional Details Related to Leases on Balance Sheet) (Details) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Operating Lease Assets [Abstract]
Noncurrent operating lease assets	$ 1,296,574	$ 57,482
Total lease assets	1,296,574
Operating lease liabilities	161,867	58,173
Noncurrent operating lease liabilities	1,305,219	$ 13,296
Total lease liabilities	$ 1,467,086

Operating Lease Assets (Schedul

Operating Lease Assets (Schedule of Minimum Lease Payments Including Weighted-Average Remaining Lease Term and Discount Rates) (Details)	Jun. 30, 2021USD ($)
Operating Lease
2021	$ 98,083
2022	318,055
2023	324,220
2024	330,894
2025	337,568
Thereafter	372,976
Total future lease payments	1,781,796
Less: imputed interest	(314,710)
Total	$ 1,467,086
Weighted Average Remaining Lease Term (years) Operating leases	5 years 2 months 12 days
Weighted Average Discount Rate Operating leases	6.75%

Notes Payable and Interest Ex_3

Notes Payable and Interest Expense (Narrative) (Details)

Jun. 30, 2021USD ($)item$ / sharesshares

Jan. 27, 2021USD ($)

Jan. 25, 2021USD ($)

Dec. 31, 2020USD ($)$ / shares

Nov. 18, 2020USD ($)loan

Nov. 14, 2018USD ($)

Jun. 30, 2021USD ($)$ / sharesshares

Jun. 30, 2020USD ($)

Jun. 30, 2021USD ($)$ / sharesshares

Jun. 30, 2021CAD ($)

Jun. 30, 2020USD ($)

Dec. 31, 2020USD ($)$ / shares

Jul. 21, 2021USD ($)

Apr. 22, 2020CAD ($)

Apr. 10, 2020USD ($)

Mar. 02, 2020$ / sharesshares

Feb. 26, 2020USD ($)

Feb. 28, 2018USD ($)

Debt Instrument [Line Items]

Warrants to purchase common stock | shares

234,500

Warrant exercise price | $ / shares

$ 2

$ 2

$ 1

Accrued interest

$ 2,324

$ 47,316

$ 2,324

$ 2,324

$ 47,316

Interest expense

$ 23,867

$ 68,088

$ 56,383

$ 145,277

Warrant Issuance Four [Member]

Debt Instrument [Line Items]

Warrants to purchase common stock | shares

227,994

227,994

227,994

Warrant exercise price | $ / shares

$ 1.67

$ 1.67

$ 1.67

Warrant exercisable period, after issuance of financing

36 months

36 months

36 months

Fair value of warrants

$ 119,103

$ 119,103

$ 119,103

BDC Term Loan [Member]

Debt Instrument [Line Items]

Maturity date

Oct. 15, 2021

Oct. 15, 2021

Repayment of promissory note

$ 48,770

Debt instrument interest rate

23.50%

23.50%

23.50%

BDC Term Loan [Member] | August 15, 2019 to November 14, 2019 [Member]

Debt Instrument [Line Items]

Principal payment

$ 8,500

BDC Term Loan [Member] | November 15, 2019 to September 14, 2020 [Member]

Debt Instrument [Line Items]

Principal payment

10,000

BDC Term Loan [Member] | September 15, 2020 to March 14, 2021 [Member]

Debt Instrument [Line Items]

Principal payment

12,000

BDC Term Loan [Member] | March 15, 2021 to September 14, 2021 [Member]

Debt Instrument [Line Items]

Principal payment

14,000

BDC Term Loan [Member] | September 15, 2021 to October 15, 2021 [Member]

Debt Instrument [Line Items]

Principal payment

$ 16,000

ACOA Note [Member]

Debt Instrument [Line Items]

Maturity date

Feb. 1, 2024

Feb. 1, 2024

Repayment of promissory note

$ 13,829

ACOA Note [Member] | November 6, 2018 to October 31, 2021 [Member]

Debt Instrument [Line Items]

Principal payment

$ 3,000

ACOA Note [Member] | November 1, 2019 to July 31, 2021 [Member]

Debt Instrument [Line Items]

Principal payment

3,500

ACOA Note [Member] | August 1, 2021 to July 31, 2022 [Member]

Debt Instrument [Line Items]

Principal payment

4,000

ACOA Note [Member] | August 1, 2022 [Member]

Debt Instrument [Line Items]

Principal payment

4,500

ACOA Note [Member] | Remaining Term [Member]

Debt Instrument [Line Items]

Principal payment

$ 2,215

Wintrust Loan [Member]

Debt Instrument [Line Items]

Principal payment

$ 33,333

Repayment of promissory note

$ 366,667

Proceeds from loan refinance

1,000,000

Debt instrument principal amount

$ 1,000,000

Debt instrument term

3 years

3 years

Interest-only term

6 months

6 months

Wintrust Loan [Member] | Prime Rate [Member]

Debt Instrument [Line Items]

Basis spread on interest rate

1.50%

1.50%

Chase Loan [Member]

Debt Instrument [Line Items]

Maturity date

Apr. 10, 2022

Apr. 10, 2022

Debt instrument principal amount

$ 891,102

Debt instrument term

2 years

2 years

Deferral period

10 months

10 months

Usage period

168 days

168 days

Debt instrument interest rate

1.00%

1.00%

1.00%

Chase Loan [Member] | 24 Week Usage Period [Member]

Debt Instrument [Line Items]

Principal payment

$ 0

TD Bank [Member]

Debt Instrument [Line Items]

Maturity date

Dec. 31, 2022

Dec. 31, 2022

Debt instrument principal amount

$ 40,000

Debt instrument interest rate

0.00%

0.00%

0.00%

Percent of loan forgiven

25.00%

25.00%

Percent of loan repaid requirement for forgiveness

75.00%

75.00%

TD Bank [Member] | April 22, 2020 to January 1, 2023 [Member]

Debt Instrument [Line Items]

Principal payment

$ 0

Unsecured Promissory Notes [Member]

Debt Instrument [Line Items]

Related party note

$ 1,823,750

$ 1,823,750

1,823,750

Accrued interest

$ 0

$ 0

$ 0

Unsecured Promissory Notes 2 [Member]

Debt Instrument [Line Items]

Debt instrument term

2 years

2 years

Unsecured Promissory Notes 3 [Member]

Debt Instrument [Line Items]

Debt instrument term

2 years

2 years

Subsequent Event [Member] | Chase Loan [Member]

Debt Instrument [Line Items]

Loan forgiveness amount, under PPP loans

$ 891,102

Certain Investors, Officers and Directors [Member] | Unsecured Promissory Notes [Member]

Debt Instrument [Line Items]

Repayment of promissory note

$ 65,000

Loss on settlement of debt

$ 668,260

Certain Investors, Officers and Directors [Member] | Unsecured Promissory Notes [Member] | Principal [Member]

Debt Instrument [Line Items]

Repayment of promissory note

$ 15,000

Debt instrument conversion amount

1,200,000

Certain Investors, Officers and Directors [Member] | Unsecured Promissory Notes [Member] | Accrued Interest [Member]

Debt Instrument [Line Items]

Repayment of promissory note

$ 34,379

Debt instrument conversion amount

$ 192,208

Certain Investors, Officers and Directors [Member] | Unsecured Promissory Notes 1 [Member]

Debt Instrument [Line Items]

Debt instrument principal amount

$ 1,080,000

Debt instrument interest rate

15.00%

15.00%

15.00%

Debt instrument pre-payment penalty

2.00%

2.00%

Certain Investors, Officers and Directors [Member] | Unsecured Promissory Notes 2 [Member]

Debt Instrument [Line Items]

Debt instrument principal amount

$ 200,000

Debt instrument interest rate

15.00%

15.00%

15.00%

Debt instrument pre-payment penalty

2.00%

2.00%

Certain Investors, Officers and Directors [Member] | Unsecured Promissory Notes 3 [Member]

Debt Instrument [Line Items]

Number of notes issued | loan

2

Debt instrument principal amount

$ 500,000

Debt instrument interest rate

15.00%

15.00%

15.00%

Debt instrument pre-payment penalty

2.00%

2.00%

Director [Member] | Credit Agreement [Member]

Debt Instrument [Line Items]

Debt instrument interest rate

15.00%

15.00%

15.00%

Maximum current borrowing capacity

$ 2,000,000

$ 2,000,000

$ 2,000,000

Amount drawn from facility

1,823,750

Cash proceeds from facility

1,280,000

Accrued interest

543,750

Borrowing under Facility

$ 1,823,750

$ 1,823,750

$ 1,823,750

Number of monthly installments | item

24

Warrant exercisable period, after issuance of financing

3 years

Credit facility fee, numerator

10.00%

Credit facility fee, denominator measurement period

30 days

Notes Payable and Interest Ex_4

Notes Payable and Interest Expense (Schedule of Notes Payable) (Details) - USD ($)	6 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Total Debt	$ 2,836,935	$ 2,140,677
Less current portion	(149,634)	(641,676)
Long-term debt, net of current portion	$ 2,687,301	1,499,001
BDC Term Loan [Member]
Debt Instrument [Line Items]
Maturity	Oct. 15, 2021
Interest Rate	23.50%
Total Debt	$ 111,318	160,088
ACOA Note [Member]
Debt Instrument [Line Items]
Maturity	Feb. 1, 2024
Total Debt	$ 97,601	111,430
Wintrust Bank [Member]
Debt Instrument [Line Items]
Maturity	Nov. 14, 2021
Interest rate description	Prime + 1.5%
Basis spread on interest rate	1.50%
Total Debt		366,667
TD Bank [Member]
Debt Instrument [Line Items]
Maturity	Dec. 31, 2022
Interest Rate	0.00%
Total Debt	$ 32,266	31,390
Chase Loan [Member]
Debt Instrument [Line Items]
Maturity	Apr. 10, 2022
Interest Rate	1.00%
Total Debt	$ 891,103	891,102
Related Party Note - Net [Member]
Debt Instrument [Line Items]
Maturity	Jun. 30, 2024
Interest Rate	15.00%
Total Debt	$ 1,704,647	$ 580,000

Stockholders' Equity (Narrative

Stockholders' Equity (Narrative) (Details)	Jun. 30, 2021USD ($)$ / sharesshares	May 12, 2021USD ($)employee$ / sharesshares	May 02, 2021USD ($)employee$ / sharesshares	Mar. 31, 2021USD ($)	Mar. 26, 2021USD ($)employee$ / sharesshares	Mar. 02, 2021USD ($)employee$ / sharesshares	Dec. 17, 2020USD ($)employee$ / sharesshares	Dec. 07, 2020USD ($)employee$ / sharesshares	Nov. 05, 2020USD ($)employee$ / sharesshares	Sep. 17, 2020USD ($)$ / shares	Aug. 07, 2020USD ($)employee$ / sharesshares	Apr. 06, 2020USD ($)employee$ / sharesshares	Mar. 24, 2020USD ($)employee$ / sharesshares	Dec. 31, 2020USD ($)item$ / sharesshares	Jun. 30, 2021USD ($)$ / sharesshares	Mar. 31, 2021USD ($)	Dec. 31, 2020USD ($)item$ / sharesshares	Mar. 31, 2020USD ($)	Jun. 30, 2021USD ($)$ / sharesshares	Jun. 30, 2020	Dec. 31, 2020USD ($)$ / sharesshares	Mar. 02, 2020$ / sharesshares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants to purchase common stock | shares																						234,500
Warrant exercise price | $ / shares														$ 2			$ 2				$ 2	$ 1
Issuance of common stock for options exercised										$ 15,000											$ 1,933,967
Strike price per share | $ / shares										$ 0.48				$ 1.25			$ 1.25				$ 1.25
Ratio of converted warrant units | item														1			1
Issuance of common stock for debt settlement, shares | shares														1,113,767
Issuance of common stock for debt settlement																					$ 2,060,468
Loss on conversion														$ 668,260
Restricted stock expense																					260,003
Equity payable	$ 100,862													$ 100,862	$ 100,862		$ 100,862		$ 100,862		$ 100,862
Number of employees, awards granted | employee			1		5		6	1	1			4	1
Options granted | shares			20,000		67,500		210,000	600,000	20,000			700,000	15,000						87,500		1,545,000
Weighted average exercise price of stock options granted | $ / shares																			$ 1.80
Weighted average grant date fair value of options granted | $ / shares			$ 1.48		$ 1.80		$ 1.83	$ 1.55	$ 0.96			$ 0.70	$ 0.65						$ 1.16
Volatility rate			74.79%		73.97%		77.41%	77.35%	77.36%			78.21%	77.56%						74.16%	77.57%
Call option value, price per share | $ / shares			$ 0.93		$ 1.16		$ 1.21	$ 1.03	$ 0.63			$ 0.47	$ 0.43
Call option value			$ 18,628		$ 78,492		$ 254,373	$ 615,495	$ 12,689			$ 326,752	$ 6,472
Units issued | shares																			575,036		284,480
Shares issued | shares														2,666,459
Proceeds from issuance of common stock, net of issuance costs														$ 3,333,074
Share-based Payment Arrangement, Tranche One, Forty-Eight Months [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Options granted | shares												500,000
Vesting rate									25.00%
Share-based Payment Arrangement, Tranche Two Forty-Eight Months [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Options granted | shares												200,000
Twelve Months [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Vesting rate			25.00%		25.00%		25.00%	25.00%				25.00%	25.00%
Thirty-Six Months [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Vesting period			36 months		36 months		36 months	36 months	36 months			36 months	36 months
Forty-Eight Months [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Vesting period												48 months
Board of Directors [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Restricted stock expense				$ 130,005
Value of units																			$ 130,005
Employees [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Restricted stock expense				$ 59,712
Value of units																			$ 59,712
Warrant Issuance One [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants to purchase common stock | shares						234,500
Warrant exercise price | $ / shares						$ 1
Number of employees, awards granted | employee						1
Adjustment to APIC						$ 234,500
Warrant Issuance Two [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants to purchase common stock | shares														2,666,459			2,666,459				2,666,459
Warrant exercise price | $ / shares	$ 1.25													$ 1.25	$ 1.25		$ 1.25		$ 1.25		$ 1.25
Warrants outstanding | shares	25,000													2,691,459	25,000		2,691,459		25,000		2,691,459
Adjustment to APIC														$ 3,333,074
Warrant Issuance Three [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants to purchase common stock | shares														2,666,459			2,666,459				2,666,459
Warrant exercise price | $ / shares	$ 2													$ 2	$ 2		$ 2		$ 2		$ 2
Warrants outstanding | shares	2,666,459														2,666,459				2,666,459
Warrant Issuance Four [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants to purchase common stock | shares	227,994														227,994				227,994
Warrant exercise price | $ / shares	$ 1.67														$ 1.67				$ 1.67
Warrants outstanding | shares	227,994														227,994				227,994
Warrant exercisable period, after issuance of financing	36 months																		36 months
Fair value of warrants	$ 119,103														$ 119,103				$ 119,103
Warrant Issuance Four, Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants to purchase common stock | shares	119,760														119,760				119,760
Warrant Issuance Four, Volume Weighted Average Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants to purchase common stock | shares	108,234														108,234				108,234
Restricted Stock Units RSU [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Restricted stock expense															$ 65,000
Number of employees, awards granted | employee							4		4		4		4
Units issued | shares							35,520		67,708		81,252		100,000
Value of units							$ 65,000		$ 65,000		$ 65,000		$ 65,000								$ 260,003
Value of units, per share | $ / shares							$ 1.83		$ 0.96		$ 0.80		$ 0.65
Unearned compensation	$ 0														$ 0				$ 0
Restricted Stock Units RSU [Member] | Board of Directors [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Restricted stock expense																		$ 65,000
Number of employees, awards granted | employee		4			4
Units issued | shares		38,924			36,112
Value of units		$ 65,002			$ 65,002											$ 65,000
Value of units, per share | $ / shares		$ 1.67			$ 1.80
Restricted Stock Units RSU [Member] | Employees [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of employees, awards granted | employee					1
Units issued | shares					1,000,000
Value of units, per share | $ / shares					$ 1.80
Restricted Stock Units RSU [Member] | Employees [Member] | Forty-Eight Months [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Vesting rate					50.00%
Vesting period					48 months
Restricted Stock Units RSU [Member] | Employees [Member] | Revenue Based Vesting, Tranche One [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Vesting rate					15.00%
Vesting period					12 months
Revenue threshold for vesting measurement					$ 25,000,000
Restricted Stock Units RSU [Member] | Employees [Member] | Revenue Based Vesting, Tranche Two [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Vesting rate					35.00%
Vesting period					12 months
Revenue threshold for vesting measurement					$ 50,000,000
Restricted Stock Units RSU [Member] | Employees [Member] | Change In Control Of Company [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Units issued | shares					300,000
Principal [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Issuance of common stock for debt settlement														$ 1,200,000
Accrued Interest [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Issuance of common stock for debt settlement														$ 192,208

Stockholders' Equity (Stock Opt

Stockholders' Equity (Stock Option Activity) (Details) - shares	May 02, 2021	Mar. 26, 2021	Dec. 17, 2020	Dec. 07, 2020	Nov. 05, 2020	Apr. 06, 2020	Mar. 24, 2020	Jun. 30, 2021	Dec. 31, 2020
Stockholders' Equity [Abstract]
Outstanding at Beginning of Period								6,007,552	5,781,884
Granted	20,000	67,500	210,000	600,000	20,000	700,000	15,000	87,500	1,545,000
Exercised									(15,000)
Forfeit/canceled								(76,406)	(814,068)
Expired								(92,180)	(490,264)
Outstanding at End of Period								5,926,466	6,007,552

Stockholders' Equity (Stock Bas

Stockholders' Equity (Stock Based Compensation Expense - Stock Options and Warrants) (Details) - Stock Options and Warrants [Member] - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 154,432	$ 123,544	$ 314,359	$ 257,757
General and Administrative [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	79,758	58,149	163,888	136,698
Sales and Marketing [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	31,068	20,921	63,813	34,598
Engineering, Research and Development [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 43,606	$ 44,474	$ 86,658	$ 86,461

Stockholders' Equity (Valuation

Stockholders' Equity (Valuation Assumptions) (Details)	May 02, 2021	Mar. 26, 2021	Dec. 17, 2020	Dec. 07, 2020	Nov. 05, 2020	Apr. 06, 2020	Mar. 24, 2020	Jun. 30, 2021	Jun. 30, 2020
Stockholders' Equity [Abstract]
Risk-free interest rate								1.01%	0.58%
Expected life (years)								6 years	6 years
Expected volatility	74.79%	73.97%	77.41%	77.35%	77.36%	78.21%	77.56%	74.16%	77.57%

Stockholders' Equity (Restricte

Stockholders' Equity (Restricted Stock Unit Activity) (Details) - shares	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Stockholders' Equity [Abstract]
Outstanding at Beginning of Period	1,436,728	1,152,248
Awarded, Shares	575,036	284,480
Outstanding at End of Period	2,011,764	1,436,728
Vested at end	1,543,014

Stockholders' Equity (Stock B_2

Stockholders' Equity (Stock Based Compensation Expense - Restricted Stock) (Details) - Restricted Stock Units RSU [Member] - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2021	Jun. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 121,021	$ 189,717	$ 65,000
General and Administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	65,003	130,005	$ 65,000
Sales and Marketing [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 56,018	$ 59,712

Fair Value Measurements (Detail

Fair Value Measurements (Details) - Fair Value, Nonrecurring [Member] - Fair Value Inputs Level 3 [Member] - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Goodwill [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill	$ 496,352	$ 496,352
Intangibles, Net [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Intangibles, net	$ 1,274,255	$ 1,368,329

Commitments and Contingencies (

Commitments and Contingencies (Narrative) (Details)	6 Months Ended	12 Months Ended
	Jun. 30, 2021USD ($)ft²	Jan. 31, 2022
Commitments And Contingencies [Line Items]
Operating lease asset	$ 1,296,574
Operating lease liability	$ 1,467,086
Lease Starting February 2021 [Member]
Commitments And Contingencies [Line Items]
Area of property | ft²	8,898
Operating lease asset	$ 1,296,574
Operating lease liability	1,467,086
Lease Starting February 2021 [Member] | Minimum [Member]
Commitments And Contingencies [Line Items]
Monthly rental expense	25,953
Lease Starting February 2021 [Member] | Maximum [Member]
Commitments And Contingencies [Line Items]
Monthly rental expense	$ 28,733
Lease Ending January 2027 [Member]
Commitments And Contingencies [Line Items]
Area of property | ft²	8,898
Operating lease asset	$ 1,271,016
Operating lease liability	$ 1,434,397
Lease abatement percentage	50.00%
Lease Ending January 2027 [Member] | Minimum [Member]
Commitments And Contingencies [Line Items]
Monthly rental expense	$ 25,953
Lease Ending January 2027 [Member] | Maximum [Member]
Commitments And Contingencies [Line Items]
Monthly rental expense	28,733
Lease Ending April 2022 [Member]
Commitments And Contingencies [Line Items]
Operating lease asset	25,559
Operating lease liability	$ 36,690
Lease Ending April 2022 [Member] | Minimum [Member]
Commitments And Contingencies [Line Items]
Area of property | ft²	3,248
Monthly rental expense	$ 2,665
Lease Ending April 2022 [Member] | Maximum [Member]
Commitments And Contingencies [Line Items]
Monthly rental expense	$ 3,371
Forecast [Member] | Lease Starting February 2021 [Member]
Commitments And Contingencies [Line Items]
Lease abatement percentage		50.00%

Related Party Transactions (Nar

Related Party Transactions (Narrative) (Details)	Jun. 30, 2021USD ($)item$ / sharesshares	Dec. 31, 2020USD ($)$ / shares	Nov. 18, 2020USD ($)	Feb. 26, 2020USD ($)	Feb. 28, 2018USD ($)	Jun. 30, 2021USD ($)$ / sharesshares	Jun. 30, 2021USD ($)$ / sharesshares	Mar. 02, 2020$ / sharesshares
Related Party Transaction [Line Items]
Accrued interest	$ 2,324	$ 47,316				$ 2,324	$ 2,324
Warrants to purchase common stock | shares								234,500
Warrants outstanding, per share | $ / shares		$ 2						$ 1
Warrant exercise price | $ / shares		$ 2						$ 1
Warrant Issuance Four [Member]
Related Party Transaction [Line Items]
Warrants to purchase common stock | shares	227,994					227,994	227,994
Warrants outstanding, per share | $ / shares	$ 1.67					$ 1.67	$ 1.67
Warrant exercisable period, after issuance of financing	36 months						36 months
Warrant exercise price | $ / shares	$ 1.67					$ 1.67	$ 1.67
Fair value of warrants	$ 119,103					$ 119,103	$ 119,103
Certain Investors, Officers and Directors [Member] | Unsecured Promissory Notes [Member]
Related Party Transaction [Line Items]
Debt instrument conversion amount		$ 1,200,000
Certain Investors, Officers and Directors [Member] | Unsecured Promissory Notes 1 [Member]
Related Party Transaction [Line Items]
Debt instrument principal amount					$ 1,080,000
Debt instrument interest rate							15.00%
Debt instrument pre-payment penalty							2.00%
Certain Investors, Officers and Directors [Member] | Unsecured Promissory Notes 2 [Member]
Related Party Transaction [Line Items]
Debt instrument principal amount				$ 200,000
Debt instrument interest rate							15.00%
Debt instrument pre-payment penalty							2.00%
Certain Investors, Officers and Directors [Member] | Unsecured Promissory Notes 3 [Member]
Related Party Transaction [Line Items]
Debt instrument principal amount			$ 500,000
Debt instrument interest rate							15.00%
Debt instrument pre-payment penalty							2.00%
Director [Member] | Credit Agreement [Member]
Related Party Transaction [Line Items]
Debt instrument interest rate	15.00%
Maximum current borrowing capacity	$ 2,000,000					2,000,000	$ 2,000,000
Amount drawn from facility						1,823,750
Cash proceeds from facility						1,280,000
Accrued interest						543,750
Number of monthly installments | item	24
Borrowing under Facility	$ 1,823,750					1,823,750	1,823,750
Accrued interest	$ 0					0	0
Warrant exercisable period, after issuance of financing	3 years
Credit facility fee, numerator	10.00%
Discount	$ 119,103					$ 119,103	$ 119,103
Principal [Member] | Certain Investors, Officers and Directors [Member] | Unsecured Promissory Notes [Member]
Related Party Transaction [Line Items]
Debt instrument conversion amount		192,208
Accrued Interest [Member] | Certain Investors, Officers and Directors [Member] | Unsecured Promissory Notes [Member]
Related Party Transaction [Line Items]
Debt instrument conversion amount		$ 668,260

Subsequent Events (Details)

Subsequent Events (Details)	Jul. 21, 2021USD ($)
Subsequent Event [Member]
Subsequent Event [Line Items]
Amount of loan forgiven	$ 891,102